Cargando…

Hypoxia-inducible factor-1 α/platelet derived growth factor axis in HIV-associated pulmonary vascular remodeling

BACKGROUND: Human immunodeficiency virus (HIV) infected patients are at increased risk for the development of pulmonary arterial hypertension (PAH). Recent reports have demonstrated that HIV associated viral proteins induce reactive oxygen species (ROS) with resultant endothelial cell dysfunction an...

Descripción completa

Detalles Bibliográficos
Autores principales: Mermis, Joel, Gu, Haihua, Xue, Bing, Li, Fang, Tawfik, Ossama, Buch, Shilpa, Bartolome, Sonja, O'Brien-Ladner, Amy, Dhillon, Navneet K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163194/
https://www.ncbi.nlm.nih.gov/pubmed/21819559
http://dx.doi.org/10.1186/1465-9921-12-103
_version_ 1782210926124990464
author Mermis, Joel
Gu, Haihua
Xue, Bing
Li, Fang
Tawfik, Ossama
Buch, Shilpa
Bartolome, Sonja
O'Brien-Ladner, Amy
Dhillon, Navneet K
author_facet Mermis, Joel
Gu, Haihua
Xue, Bing
Li, Fang
Tawfik, Ossama
Buch, Shilpa
Bartolome, Sonja
O'Brien-Ladner, Amy
Dhillon, Navneet K
author_sort Mermis, Joel
collection PubMed
description BACKGROUND: Human immunodeficiency virus (HIV) infected patients are at increased risk for the development of pulmonary arterial hypertension (PAH). Recent reports have demonstrated that HIV associated viral proteins induce reactive oxygen species (ROS) with resultant endothelial cell dysfunction and related vascular injury. In this study, we explored the impact of HIV protein induced oxidative stress on production of hypoxia inducible factor (HIF)-1α and platelet-derived growth factor (PDGF), critical mediators implicated in the pathogenesis of HIV-PAH. METHODS: The lungs from 4-5 months old HIV-1 transgenic (Tg) rats were assessed for the presence of pulmonary vascular remodeling and HIF-1α/PDGF-BB expression in comparison with wild type controls. Human primary pulmonary arterial endothelial cells (HPAEC) were treated with HIV-associated proteins in the presence or absence of pretreatment with antioxidants, for 24 hrs followed by estimation of ROS levels and western blot analysis of HIF-1α or PDGF-BB. RESULTS: HIV-Tg rats, a model with marked viral protein induced vascular oxidative stress in the absence of active HIV-1 replication demonstrated significant medial thickening of pulmonary vessels and increased right ventricular mass compared to wild-type controls, with increased expression of HIF-1α and PDGF-BB in HIV-Tg rats. The up-regulation of both HIF-1α and PDGF-B chain mRNA in each HIV-Tg rat was directly correlated with an increase in right ventricular/left ventricular+septum ratio. Supporting our in-vivo findings, HPAECs treated with HIV-proteins: Tat and gp120, demonstrated increased ROS and parallel increase of PDGF-BB expression with the maximum induction observed on treatment with R5 type gp-120(CM). Pre-treatment of endothelial cells with antioxidants or transfection of cells with HIF-1α small interfering RNA resulted in abrogation of gp-120(CM )mediated induction of PDGF-BB, therefore, confirming that ROS generation and activation of HIF-1α plays critical role in gp120 mediated up-regulation of PDGF-BB. CONCLUSION: In summary, these findings indicate that viral protein induced oxidative stress results in HIF-1α dependent up-regulation of PDGF-BB and suggests the possible involvement of this pathway in the development of HIV-PAH.
format Online
Article
Text
id pubmed-3163194
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31631942011-08-29 Hypoxia-inducible factor-1 α/platelet derived growth factor axis in HIV-associated pulmonary vascular remodeling Mermis, Joel Gu, Haihua Xue, Bing Li, Fang Tawfik, Ossama Buch, Shilpa Bartolome, Sonja O'Brien-Ladner, Amy Dhillon, Navneet K Respir Res Research BACKGROUND: Human immunodeficiency virus (HIV) infected patients are at increased risk for the development of pulmonary arterial hypertension (PAH). Recent reports have demonstrated that HIV associated viral proteins induce reactive oxygen species (ROS) with resultant endothelial cell dysfunction and related vascular injury. In this study, we explored the impact of HIV protein induced oxidative stress on production of hypoxia inducible factor (HIF)-1α and platelet-derived growth factor (PDGF), critical mediators implicated in the pathogenesis of HIV-PAH. METHODS: The lungs from 4-5 months old HIV-1 transgenic (Tg) rats were assessed for the presence of pulmonary vascular remodeling and HIF-1α/PDGF-BB expression in comparison with wild type controls. Human primary pulmonary arterial endothelial cells (HPAEC) were treated with HIV-associated proteins in the presence or absence of pretreatment with antioxidants, for 24 hrs followed by estimation of ROS levels and western blot analysis of HIF-1α or PDGF-BB. RESULTS: HIV-Tg rats, a model with marked viral protein induced vascular oxidative stress in the absence of active HIV-1 replication demonstrated significant medial thickening of pulmonary vessels and increased right ventricular mass compared to wild-type controls, with increased expression of HIF-1α and PDGF-BB in HIV-Tg rats. The up-regulation of both HIF-1α and PDGF-B chain mRNA in each HIV-Tg rat was directly correlated with an increase in right ventricular/left ventricular+septum ratio. Supporting our in-vivo findings, HPAECs treated with HIV-proteins: Tat and gp120, demonstrated increased ROS and parallel increase of PDGF-BB expression with the maximum induction observed on treatment with R5 type gp-120(CM). Pre-treatment of endothelial cells with antioxidants or transfection of cells with HIF-1α small interfering RNA resulted in abrogation of gp-120(CM )mediated induction of PDGF-BB, therefore, confirming that ROS generation and activation of HIF-1α plays critical role in gp120 mediated up-regulation of PDGF-BB. CONCLUSION: In summary, these findings indicate that viral protein induced oxidative stress results in HIF-1α dependent up-regulation of PDGF-BB and suggests the possible involvement of this pathway in the development of HIV-PAH. BioMed Central 2011 2011-08-05 /pmc/articles/PMC3163194/ /pubmed/21819559 http://dx.doi.org/10.1186/1465-9921-12-103 Text en Copyright ©2011 Mermis et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Mermis, Joel
Gu, Haihua
Xue, Bing
Li, Fang
Tawfik, Ossama
Buch, Shilpa
Bartolome, Sonja
O'Brien-Ladner, Amy
Dhillon, Navneet K
Hypoxia-inducible factor-1 α/platelet derived growth factor axis in HIV-associated pulmonary vascular remodeling
title Hypoxia-inducible factor-1 α/platelet derived growth factor axis in HIV-associated pulmonary vascular remodeling
title_full Hypoxia-inducible factor-1 α/platelet derived growth factor axis in HIV-associated pulmonary vascular remodeling
title_fullStr Hypoxia-inducible factor-1 α/platelet derived growth factor axis in HIV-associated pulmonary vascular remodeling
title_full_unstemmed Hypoxia-inducible factor-1 α/platelet derived growth factor axis in HIV-associated pulmonary vascular remodeling
title_short Hypoxia-inducible factor-1 α/platelet derived growth factor axis in HIV-associated pulmonary vascular remodeling
title_sort hypoxia-inducible factor-1 α/platelet derived growth factor axis in hiv-associated pulmonary vascular remodeling
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163194/
https://www.ncbi.nlm.nih.gov/pubmed/21819559
http://dx.doi.org/10.1186/1465-9921-12-103
work_keys_str_mv AT mermisjoel hypoxiainduciblefactor1aplateletderivedgrowthfactoraxisinhivassociatedpulmonaryvascularremodeling
AT guhaihua hypoxiainduciblefactor1aplateletderivedgrowthfactoraxisinhivassociatedpulmonaryvascularremodeling
AT xuebing hypoxiainduciblefactor1aplateletderivedgrowthfactoraxisinhivassociatedpulmonaryvascularremodeling
AT lifang hypoxiainduciblefactor1aplateletderivedgrowthfactoraxisinhivassociatedpulmonaryvascularremodeling
AT tawfikossama hypoxiainduciblefactor1aplateletderivedgrowthfactoraxisinhivassociatedpulmonaryvascularremodeling
AT buchshilpa hypoxiainduciblefactor1aplateletderivedgrowthfactoraxisinhivassociatedpulmonaryvascularremodeling
AT bartolomesonja hypoxiainduciblefactor1aplateletderivedgrowthfactoraxisinhivassociatedpulmonaryvascularremodeling
AT obrienladneramy hypoxiainduciblefactor1aplateletderivedgrowthfactoraxisinhivassociatedpulmonaryvascularremodeling
AT dhillonnavneetk hypoxiainduciblefactor1aplateletderivedgrowthfactoraxisinhivassociatedpulmonaryvascularremodeling